Skip to main content
. 2012 Dec;86(24):13384–13396. doi: 10.1128/JVI.07234-11

Fig 2.

Fig 2

In vitro selection of TPV-resistant variants using multidrug-resistant clinical HIV-1 isolates. A mixture of 11 multi-PI-resistant HIV-1 isolates (HIV11MIX), four multidrug-resistant clinical HIV-1 isolates (HIVB, HIVC, HIVG, and HIVTM), and an infectious molecular HIV-1 clone (cHIVNL4-3) were propagated in the presence of increasing concentrations of TPV in MT-4 cells. The selection was carried out in a cell-free manner for a total of 10 to 15 passages with drug concentrations escalating from the IC50 for each virus up to 15 μM. The nucleotide sequences of proviral DNA were determined using the cell lysates of HIV-1-infected MT-4 cells at the termination of each indicated passage.